NEW YORK (GenomeWeb News) — Researchers working with biomarkers may soon see a new set of guidelines that will cover how biomarkers should be used in clinical trials, the America Association for Cancer Research said last week.
 
The guidelines will be co-developed by the National Cancer Institute, the US Food and Drug Administration, the AACR, and a group of representatives from academia, industry, and patient advocates, as part of a group dubbed the Cancer Biomarker's Collaborative.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.